RxDoctor Payments DataLook up a doctor →

Pinky Agarwal, MD

Neurology · Kirkland, WANPI 1245223296

Payments from drug & device makers

$5,402,437in general payments, 2019–2025

Across 1,688 payments — averaging $3200.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$2M
  • Biogen$813K
  • Eli Lilly$728K
  • Boston Scientific$316K
  • MDD US Operations, LLC$292K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$240K
  • plus $1M from 51 others
$24,641in research payments, 2019–2025

Across 4 payments — averaging $6160.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$25K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.83$1,986,837
Biogen7$813,340
Eli Lilly23$728,448
Boston Scientific36$315,642
MDD US Operations, LLC332$292,477
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)76$239,681
Acadia Pharmaceuticals Inc234$167,092
Takeda Pharmaceuticals U.S.A., Inc.38$160,540
Sage Therapeutics, LLC5$157,895
Kyowa Kirin, Inc.88$114,533
Amneal Pharmaceuticals LLC121$86,875
Adamas Pharmaceuticals, Inc.85$67,453
Novo Nordisk AS27$64,518
Neurocrine Biosciences, Inc.112$61,385
AbbVie(2 entities)73$54,160
Acorda Therapeutics, Inc65$39,447
Merz Pharmaceuticals, LLC49$21,221
Tanabe Pharma America, Inc.9$8,985
Roche TCRC, Inc.4$5,492
Titan Pharmaceuticals, Inc.5$3,461
Sunovion Pharmaceuticals Inc.8$3,071
Lundbeck LLC1$2,250
Avion Pharmaceuticals5$1,844
Bayer10$1,688
Teva Pharmaceuticals USA, Inc.44$774
Novartis43$557
Cala Health, Inc.1$300
Bristol Myers Squibb24$269
Abbott2$184
Supernus Pharmaceuticals, Inc.5$179
Lilly USA, LLC9$169
UCB, Inc.6$150
Medtronic(2 entities)5$147
Johnson & Johnson5$143
TG Therapeutics, Inc.7$130
Genentech USA, Inc.2$129
Eisai Inc.2$124
CSL Behring5$113
EMD Serono, Inc.4$93
Novo Nordisk2$81
Merz North America, Inc.3$70
Sanofi3$60
SK Life Science, Inc.2$55
Argenx US, Inc.2$45
Vertical Pharmaceuticals, LLC2$43
Impel Pharmaceuticals Inc.2$39
GE HealthCare2$32
Ipsen Biopharmaceuticals, Inc1$29
Alnylam Pharmaceuticals Inc.1$28
Octapharma USA, Inc.1$25
Pfizer1$23
E.r. Squibb & Sons, L.L.C.1$22
Insightec,inc1$22
Biohaven Pharmaceuticals, Inc.1$19
Amgen1$17
Neurelis, Inc.1$17
Ultragenyx Pharmaceutical Inc.1$15

How this compares

$5,402,437 in reported general payments places this provider in the 95th percentile of 418 neurology providers in Washington.

See all neurology providers in Washington →

Medicare billing

Part B allowed, 2024
$66,069
Medicare patients
188
Services billed
920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Kirkland

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →